Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry R Davis

Showing results (131-140 of 185) with videos related to

Pageof 19
Sort By:
Journal of Human Hypertension|February 27, 2019
Association of orthostatic hypertension with mortality in the Systolic Hypertension in the Elderly ProgramWilliam J Kostis, Davit Sargsyan, Choukri Mekkaoui, et al.
Plos Medicine|June 1, 2021
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysisAna-Catarina Pinho-Gomes, Luis Azevedo, Emma Copland, et al.
Journal of the American Society of Hypertension : JASH|December 3, 2014
Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHATJosé-Miguel Yamal, Suzanne Oparil, Barry R Davis, et al.
Lancet (London, England)|April 26, 2026
Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysisGuyu Zeng, Zeinab Bidel, Qianqian Yang, et al.
The American Journal of Cardiology|November 22, 2015
Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT])Michael H Alderman, Barry R Davis, Linda B Piller, et al.
Plos One|October 7, 2016
Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell AnemiaBeverly A Schaefer, Jonathan M Flanagan, Ofelia A Alvarez, et al.
Hypertension (Dallas, Tex. : 1979)|July 24, 2023
Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-AnalysisZeinab Bidel, Milad Nazarzadeh, Dexter Canoy, et al.
Plos Medicine|March 9, 2016
Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-AnalysesFerrán Catalá-López, Diego Macías Saint-Gerons, Diana González-Bermejo, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 2017
Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)Sanket S Dhruva, Chenxi Huang, Erica S Spatz, et al.
American Journal of Hematology|June 20, 2015
Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: baseline results from the TWiTCH trialJohn C Wood, Sara Pressel, Zora R Rogers, et al.
Pageof 19

Showing results (131-140 of 185) with videos related to

Sort By:
Pageof 19
Journal of Human Hypertension|February 27, 2019
Association of orthostatic hypertension with mortality in the Systolic Hypertension in the Elderly ProgramWilliam J Kostis, Davit Sargsyan, Choukri Mekkaoui, et al.
Plos Medicine|June 1, 2021
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysisAna-Catarina Pinho-Gomes, Luis Azevedo, Emma Copland, et al.
Journal of the American Society of Hypertension : JASH|December 3, 2014
Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHATJosé-Miguel Yamal, Suzanne Oparil, Barry R Davis, et al.
Lancet (London, England)|April 26, 2026
Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysisGuyu Zeng, Zeinab Bidel, Qianqian Yang, et al.
The American Journal of Cardiology|November 22, 2015
Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT])Michael H Alderman, Barry R Davis, Linda B Piller, et al.
Plos One|October 7, 2016
Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell AnemiaBeverly A Schaefer, Jonathan M Flanagan, Ofelia A Alvarez, et al.
Hypertension (Dallas, Tex. : 1979)|July 24, 2023
Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-AnalysisZeinab Bidel, Milad Nazarzadeh, Dexter Canoy, et al.
Plos Medicine|March 9, 2016
Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-AnalysesFerrán Catalá-López, Diego Macías Saint-Gerons, Diana González-Bermejo, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 2017
Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)Sanket S Dhruva, Chenxi Huang, Erica S Spatz, et al.
American Journal of Hematology|June 20, 2015
Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: baseline results from the TWiTCH trialJohn C Wood, Sara Pressel, Zora R Rogers, et al.
Pageof 19